Put companies on watchlist
JP Jenkins Ltd
ISIN: GB00BMT80K89
WKN: A3DWFL
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

JP Jenkins Ltd · ISIN: GB00BMT80K89 · EQS - Company News (1 News)
Country: Great Britain · Primary market: United Kingdom · EQS NID: 1891799
29 April 2024 11:25AM

Molecular Energies PLC Shares now trading on JP Jenkins


JP Jenkins Ltd
Molecular Energies PLC Shares now trading on JP Jenkins

29-Apr-2024 / 10:25 GMT/BST
The issuer is solely responsible for the content of this announcement.


29th April 2024

JPJ: MEN

Molecular Energies PLC

 

Shares now trading on JP Jenkins

 

 

29th April 2024 – Shares in Molecular Energies PLC (https://www.molecularenergiesplc.com) have been admitted to trade on JP Jenkins share dealing platform. Molecular Energies PLC is based at Carrwood Park, Selby Road, Leeds, England, LS15 4LG and is registered as a company in England and Wales under Companies House, company number 05104249.

 

Molecular Energies has four primary business divisions – an innovation arm focussing on the development of sustainable aviation fuel and other green energy solutions; ongoing receipts from the sale of its oil production operations in Argentina; a c18% holding in AIM-quoted ATOME plc, a green fertiliser project developer; and a 75% holding in Green House Capital Group, a carbon removal business focussed on biomass to biochar projects.

 

JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).

 

Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. Trades can be conducted, and limits can be accepted, during normal business hours. Shareholders or potential investors can place limits via their existing UK regulated stockbroker.

 

The indicative pricing for the ordinary shares (ISIN: GB00BMT80K89), as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/company/molecular-energies/).

 

Veronika Oswald, Commercial Director of JP Jenkins said: “We welcome Molecular Energies and its directors to JP Jenkins. We look forward to supporting company’s existing and new shareholders to have continued transparency and liquidity access.”

 

 

For further information, please contact:

 

JP Jenkins Limited

Veronika Oswald (Director)

+44 (0)20 7469 0937

 

 



Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1891799  29-Apr-2024 

fncls.ssp?fn=show_t_gif&application_id=1891799&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - JP Jenkins Ltd
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.